Psychology
Psychometrics
100%
Convergent Validity
66%
Social Support
58%
Chronic Pain
50%
Subjective Well-Being
50%
Cultural Adaptation
50%
Test-Retest Reliability
50%
Coping Behavior
50%
Self-Efficacy
50%
Emotional Distress
50%
Blood Pressure
50%
Anxiety Disorder
50%
Pessimism
33%
Positive Affect
33%
Negative Affect
33%
Myocardial Infarction
25%
Mixed Methods
25%
Linear Regression
25%
Behavior Modification
25%
Behavior Change Technique
25%
Social Environment
25%
Pharmacological Treatment
25%
Breast Cancer
25%
Drug Therapy
25%
Perceived Social Support
20%
Cultural Contexts
16%
Concurrent Validity
16%
Life Satisfaction
16%
Quality of Life
10%
Adaptive Coping
8%
Semistructured Interview
8%
Descriptive Result
8%
Autonomy
8%
Medicine and Dentistry
Secondary Prevention
50%
Randomized Controlled Trial
50%
Cardiovascular System
50%
Low Density Lipoprotein Cholesterol
50%
Anxiety Disorder
50%
Malignant Neoplasm
50%
Depressive Anxiety
50%
Emotional Stress
50%
Acceptance and Commitment Therapy
50%
Arm
33%
Disease
25%
K-Complex
25%
Breast Cancer
25%
Listlessness
25%
Restlessness
25%
Diseases
25%
Emotions
25%
Primary Outcome
23%
Systolic Blood Pressure
16%
Unstable Angina Pectoris
16%
Antiplatelet Drug
16%
Behavior Modification
16%
Acute Heart Infarction
16%
Antihypertensive Agent
16%
Medication Compliance
16%
Arteriosclerosis Obliterans
16%
Cerebrovascular Disease
16%
Adverse Event
16%
Drug Therapy
16%
Diastolic Blood Pressure
16%
Prevalence
16%
Patient Compliance
16%
Linear Regression Analysis
16%
Blood Pressure
16%
Controlled Clinical Trial
16%
Health System
16%
Behavioral Change
16%
Thromboxane B2
16%
Mixed Methods
16%
Registration Number
7%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Atherosclerosis
100%
Randomized Controlled Trial
100%
Low Density Lipoprotein Cholesterol
50%
Beta Adrenergic Receptor Blocking Agent
25%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
25%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Acute Heart Infarction
12%
11 Oxothromboxane B2
12%
Antiplatelet
12%
Angiotensin Receptor Antagonist
12%
Unstable Angina Pectoris
12%
Controlled Clinical Trial
12%
Thromboxane B2
12%
Prevalence
12%
Antihypertensive Agent
12%
Peripheral Occlusive Artery Disease
12%
Cerebrovascular Disease
12%
Antithrombocytic Agent
12%
Cardiovascular Disease
12%
Adverse Event
12%